eClinical Solutions Releases Newest Version Of elluminate® For Clinical Data Aggregation, Standardization, and Analytics-ACT
eClinical Solutions, LLC, a leading provider of data management services and technologies, today announced the release of elluminate®.
MANSFIELD, MA – January 20, 2015
– eClinical Solutions, LLC, a leading provider of data management services and technologies, today announced the release of the latest version of their end to end clinical data repository and analytics platform, elluminate
®
. The elluminate
®
platform integrates and standardizes clinical and operational data, regardless of source, to enable advanced analytics and adhoc reporting capabilities. This release enhances the ability to visualize operational data such as metrics, audit trail, and queries to support risk based monitoring and site management. The release also enhances the ability to define workflows to support advanced data integrations. "We have a unique perspective on industry needs to support clinical drug development," explains Robert Arnesen, President eClinical Solutions. "Our experience in clinical data management coupled with feedback from existing clients enables us to shape our platform to meet the day-to-day needs of clinical and operational personnel." elluminate
®
is a breakthrough technology built specifically to help the life sciences industry aggregate and standardize disparate data from multiple sources, and allows users to perform analytics and view data across trials. With feedback from clients, and their teams leveraging the platform daily, they continue the innovation based on "real world" use and experience in clinical development. "With elluminate
®
we strive to make clinical research data acquisition, standardization, aggregation, and analytics absolutely simple and easy," says Raj Indupuri, CEO of eClinical Solutions. "Allowing complete transparency and access to all clinical and operational data through powerful analytics empowers personnel to be more responsive to development and business needs," says Indupuri. In addition, elluminate
®
provides standards compliance, metadata management, and document management capabilities in a cloud based 21 CFR Part 11 compliant environment. "Our platform has helped clients expedite clinical research development and aid in making better decisions faster," says Indupuri. "We will continue to innovate to further empower the industry and assist our clients to bring needed therapies to market."
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
